30
C. Sankar et al. / Journal of Molecular Structure 1083 (2015) 27–38
H-p0); 13C NMR: d = 69.61 (C-2), 60.04 (C-6), 42.97 (C-3), 33.79
(C-5), 22.77, 21.22 (ACH3(e,a) at C-3), 170.37 (C@O), 161.69
Table 3
Crystal data and structure refinement of compound 16.
(C@N), 149.98 (pyridine
a), 121.58 (pyridine b), 140.36 (pyridine
Empirical formula
Formula weight
Temperature
C25H26N4O
398.5
293(2) K
ipso carbon), 144.10, 141.12 (C-60, C-20), 128.95, 128.16 (C-o,
C-o0), 126.76 (C-2000, C-6000, 127.31, 127.16 (C-p, C-p0) ppm.
Wavelength
0.71073 Å
Crystal system, space group
Unit cell dimension
Triclinic, Pꢁ1
a = 6.21280(10) Å,
a
= 65.29(10)°
3,3-Dimethyl-2r,6c-bis(p-methylphenyl)piperidin-4-one isonicotinylhyd-
razone (17). White powder, yield 75%, mp: 206–207 °C; 1H NMR:
d = 3.72 (s, 1H, H-2a), 3.80 (d, J6a,5a = 11.64 Hz, 1H, 6a), 2.28 (t, 1H,
H-5a), 2.95 (d, J5a,5e = 13.50 Hz, 1H, H-5e), 11.03 (s, 1H, ACOANHA),
b = 12.8346(3), Å, b = 78.82(10)°
c = 15.0022(3), Å,
1065.62(4) Å3
2, 1.242 Mg/m3
0.078 mmꢁ1
424
c = 86.94(10)°
Volume
Z, density
Absorption coefficient
F(000)
Crystal size
1.02, 1.13 (s, 6H, ACH3(a), CH3(e) at C-3), 8.72 (d, 2H, pyridine
a),
7.73 (d, 2H, pyridine b), 7.42 (d, 2H, H-m), 7.34 (d, 2H, H-m0); 13C
NMR: d = 69.35 (C-2), 59.78 (C-6), 42.99 (C-3), 33.85 (C-5), 21.18,
20.58 (CH3(a,e) at C-3), 22.69 (CH3 at C-20000 and C-60000), 170.81 (C@O),
0.22 ꢂ 0.18 ꢂ 0.16 mm
Theta range for data collection
Limiting indices
1.78–28.61°
ꢁ8 6 h 6 8, ꢁ17 6 k 6 17, ꢁ20 6 l 6 20
25,613/5420 [R(int) = 0.0232]
25 99.8%
Semi-empirical from equivalents
Full-materix least square on F2
5420/0/271
161.55 (C@N), 149.95 (pyridine a), 121.51 (pyridine b), 136.14 (pyri-
Reflections collected
Completeness to theta
Absorption correction
Refinement method on
Data/restraints/parameter s
Goodness-of-fit on F2
Final R Indices [I > 2sigma(I)]
CCDC No
dine ipso carbon), 141.11, 137.35 (C-60, C-20), 126.58 (C-o, C-o0), 127.89
(C-m, C-m0), 128.68 (C-p, C-p0) ppm.
3,3-Dimethyl-2r,6c-bis(p-methoxyphenyl)piperidin-4-one isonicotinylhyd-
razone (18). White powder, yield 72%, mp: 180–182 °C; 1H NMR:
d = 3.72 (s, 1H, H-2a), 3.80 (1H, 6a), 2.28 (t, 1H, H-5a), 2.95 (d,
J5e,5a = 14.5, J5e,6a = 3.0 Hz, 1H, H-5e), 11.03 (s, 1H, ACOANHA), 1.02,
1.041
[I > 2sigma(I) R1 = 0.0505, wR2 = 0.1406
653067
1.13 (s, 6H, ACH3(a), CH3(e) at C-3), 8.72 (d, 2H, pyridine
a), 7.73 (d,
C-3), 8.71 (d, 2H, pyridine
a
), 7.73 (d, 2H, pyridine b), 7.55 (d, 2H, H-
2H, pyridine b), 7.42 (d, 2H, H-o), 7.34 (d, 2H H-o0), 7.16 (m, 6H, H-m,
H-m0); 13C NMR: d = 69.02 (C-2), 59.49 (C-6), 43.10 (C-3), 33.92 (C-5),
22.73, 21.17 (CH3(a,e) at C-3), 55.01 (OCH3 at C-20000, C-60000)ppm, 170.83
o), 7.46 (d, 2H, H-o0), 7.28-7.39 (m, 4H, H-m, H-m0); 13C NMR:
d = 69.61 (C-2), 60.04 (C-6), 42.97 (C-3), 33.79 (C-5), 22.77, 21.22
(ACH3(e,a) at C-3), 169.65 (C@O), 161.67 (C@N), 149.95 (pyridine a),
(C@O), 161.62 (C@N), 149.99 (pyridine
a), 121.56 (pyridine b),
121.53 (pyridine b), 139.21 (pyridine ipso carbon), 142.97, 141.07
(C-60, C-20), 128.95, 128.16 (C-o, C-o0), 126.76 (C-m, C-m0), 127.31,
127.16 (C-p, C-p0) ppm.
136.21 (pyridine ipso carbon), 141.13, 136.19 (C-60, C-20), 129.84,
127.80 (C-o, C-o0), 113.56, 112.75 (C C-m, C-m0), 158.41(C-p, C-p0).
3,3-Dimethyl-2r,6c-bis(p-chlorophenyl)piperidin-4-one isonicotinylhyd-
razone (19). White powder, yield 94%, mp: 210–211 °C; 1H NMR:
d = 3.76 (s, 1H, H-2a), 3.85 (d, J6a,5a = 11.4 Hz, 1H, H-6a), 2.28 (t, 1H,
H-5a), 3.01 (d, J5e,5a = 13.4 Hz, 1H, H-5e), 2.67 (bs, 1H, NH), 11.03 (s,
3,3-Dimethyl-2r,6c-bis(p-flurophenyl)piperidin-4-one isonicotinylhyd-
razone (20). White powder, yield 85%, mp: 196–197 °C; 1H NMR:
d = 3.75 (s, 1H, H-2a), 3.84 (d, J6a,5e = 11.68 Hz, 1H, H-6a) 2.23 (t,
1H, H-5a), 2.99 (d, J5a,5e = 12.96 Hz, 1H, H-5e), 2.77 (bs, 1H, NH),
1H, ACOANHA), 1.03, 1.14 (s, 6H, ACH3(a)
,
CH3(e) at
Fig. 2. ORTEP diagram of compound 16.